Proactive Investors - Run By Investors For Investors

LeanLife closes first round of financing, raises $1.15 million

The offering consisted of 22.9 million units at a price of C$0.05 for total gross proceeds of $1,146,000 million
LeanLife closes first round of financing, raises $1.15 million
LeanLife's products are extracted from flax seeds, a plentiful and non-animal source of omega-3

LeanLife Health Inc (CSE:LLP) announced Friday it has closed its second round of funding, raising $1.14 million. 

The company said funds will be used for used for general working capital.

The offering consisted of 22.9 million units at a price of C$0.05 for total gross proceeds of $1,146,000 million. 

READ: LeanLife Health taps Chris Nichols as operations advisor

Each unit will consist of one share and one transferable share purchase warrant, which is exercisable into one further share at a price of C$0.075 per share for three years from closing.

LeanLife delivers high concentration levels of omega-3 as a nutritional additive. Its products are for use in commercial food processing. 

The group's products are extracted from flaxseeds, a plentiful and non-animal source of omega-3.

Such products will include ingredients for making and/or fortifying commercial foods such as bread, noodles, juices, yogurt and cheese.

 

Contact Katie Lewis at [email protected]

View full LLP profile View Profile

LeanLife Health Timeline

Newswire
February 07 2019

Related Articles

1550834286_shutterstock_651647128.jpg
February 22 2019
The company is developing drugs for blood disorders, metabolic diseases and curbing alcohol use
Cameron Durrant
March 04 2019
A goal is to improve the safety of CAR-T therapies, used in the treatment of children with acute lymphoblastic leukemia and adults with advanced lymphomas
skin cream
October 25 2018
The cream is currently undergoing its first-in-human studies, with researchers assessing its skin irritancy, moisturisation potential and skin barrier function
Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use